SAN FRANCISCO , March 09, 2017 -- Hagens Berman Sobol Shapiro LLP reminds investors in BT Group plc (NYSE:BT) of the March 27, 2017 Lead Plaintiff deadline.
If you purchased or otherwise acquired securities of BT between May 24, 2012 and January 23, 2017 and suffered over $100,000 in losses contact Hagens Berman Sobol Shapiro LLP. For more information visit:
https://www.hbsslaw.com/cases/BT
or contact Reed Kathrein, who is leading the firm’s investigation, by calling 510-725-3000 or emailing [email protected].
On January 24, 2017 BT filed its Form 6-K with the U.S. Securities and Exchange Commission. The Company disclosed that an internal accounting investigation identified a significant “overstatement of earnings in our Italian business over a number of years.”
The Company stated that the required adjustments would total approximately £530 million. This news drove the price of BT shares down over 20% on January 24, 2017.
“We’re focused on the material failures of BT’s financial controls and when management knew or should have known they were broken,” said Hagens Berman partner Reed Kathrein.
Whistleblowers: Persons with non-public information regarding BT should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new SEC whistleblower program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 510-725-3000 or email [email protected].
About Hagens Berman
Hagens Berman is a national investor-rights law firm headquartered in Seattle, Washington with offices in 10 cities. The Firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the Firm and its successes can be found at www.hbsslaw.com. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.
Contact: Reed Kathrein, 510-725-3000


Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Starlink Plans Satellite Orbit Reconfiguration in 2026 to Boost Space Safety
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital 



